Cardiovascular manifestations of endocrine dysfunction

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 25, Issue 4, 2011, Pages 705-720

  Deegan, Robert J ^a   Furman, William R ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

acromegaly; adrenal insufficiency; androgens; carcinoid tumor; Cushing syndrome; hyperthyroidism; hypothyroidism; pheochromocytoma

Indexed keywords

ANABOLIC AGENT;

ACROMEGALY; ADRENAL CORTEX DISEASE; AORTA ANEURYSM; AORTA VALVE DISEASE; CARCINOID; CARDIOMYOPATHY; CARDIOVASCULAR DISEASE; CUSHING SYNDROME; ENDOCRINE DISEASE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; HYPERTENSIVE CRISIS; HYPERTHYROIDISM; HYPOTHYROIDISM; MITRAL VALVE DISEASE; NEUROENDOCRINE TUMOR; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; QT PROLONGATION; REVIEW; THYROID DISEASE;

ACROMEGALY; ADRENAL CORTEX DISEASES; ADRENAL GLAND NEOPLASMS; ANIMALS; CARCINOID TUMOR; CARDIOVASCULAR DISEASES; ENDOCRINE SYSTEM DISEASES; HUMANS; PHEOCHROMOCYTOMA; THYROID DISEASES;

EID: 80052767388     PISSN: 10530770     EISSN: 15328422     Source Type: Journal    
DOI: 10.1053/j.jvca.2010.12.001     Document Type: Review

References (316)

1. P.G. Barash, R.K. Stoelting, and M.K. Cahalan Clinical Anesthesia (ed 6) 2009 Lippincott Williams & Wilkins Philadelphia, PA
2. S.F. Yao, M.L. Fonte, and V. Malhotra Yao and Artusio's Anesthesiology: Problem-Oriented Patient Management (ed 6) 2007 Lippincott Williams & Wilkins Philadelphia, PA
3. J.A. Franklyn, P. Maisonneuve, and M.C. Sheppard Mortality after the treatment of hyperthyroidism with radioactive iodine N Engl J Med 338 1998 712 718 (Pubitemid 28115089)
4. D. Salvatore, H. Tu, and J.W. Harney Type 2 iodothyronine deiodinase is highly expressed in human thyroid J Clin Invest 98 1996 962 968 (Pubitemid 26293314)
5. J.D. Klemperer, K. Ojamaa, and I. Klein Thyroid hormone therapy in cardiovascular disease Prog Cardiovasc Dis 38 1996 329 336 (Pubitemid 26035434)
6. K. Ojamaa, J.D. Klemperer, and I. Klein Acute effects of thyroid hormone on vascular smooth muscle Thyroid 6 1996 505 512 (Pubitemid 26398659)
7. E. Bussemaker, R. Popp, and B. Fisslthaler Hyperthyroidism enhances endothelium-dependent relaxation in the rat renal artery Cardiovasc Res 59 2003 181 188
8. R. Napoli, B. Biondi, and V. Guardasole Impact of hyperthyroidism and its correction on vascular reactivity in humans Circulation 104 2001 3076 3080 (Pubitemid 34014060)
9. K.W. Park, H.B. Dai, and K. Ojamaa The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries Anesth Analg 85 1997 734 738 (Pubitemid 27418872)
10. J.D. Klemperer, I. Klein, and M. Gomez Thyroid hormone treatment after coronary-artery bypass surgery N Engl J Med 333 1995 1522 1527
11. K. Fukuyama, T. Ichiki, and K. Takeda Downregulation of vascular angiotensin II type 1 receptor by thyroid hormone Hypertension 41 2003 598 603 (Pubitemid 36314638)
12. N. Gassanov, F. Er, and J. Endres-Becker Distinct regulation of cardiac I(f) current via thyroid receptors alpha1 and beta1 Pflugers Arch 458 2009 1061 1068
13. N. Gassanov, F. Er, and G. Michels Divergent regulation of cardiac KCND3 potassium channel expression by the thyroid hormone receptors alpha1 and beta1 J Physiol 587 2009 1319 1329
14. R. Valcavi, C. Menozzi, and E. Roti Sinus node function in hyperthyroid patients J Clin Endocrinol Metab 75 1992 239 242
15. V. Cacciatori, F. Bellavere, and A. Pezzarossa Power spectral analysis of heart rate in hyperthyroidism J Clin Endocrinol Metab 81 1996 2828 2835 (Pubitemid 26323873)
16. J.L. Chen, H.-W. Chiu, and Y.-J. Tseng Hyperthyroidism is characterized by both increased sympathetic and decreased vagal modulation of heart rate: Evidence from spectral analysis of heart rate variability Clin Endocrinol (Oxf) 64 2006 611 616 (Pubitemid 43774998)
17. C.T. Sawin, A. Geller, and P.A. Wolf Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons N Engl J Med 331 1994 1249 1252 (Pubitemid 24333188)
18. L. Kokkonen, S. Majahalme, and T. Koobi Atrial fibrillation in elderly patients after cardiac surgery: Postoperative hemodynamics and low postoperative serum triiodothyronine J Cardiothorac Vasc Anesth 19 2005 182 187 (Pubitemid 40544446)
19. T. Feldman, K.M. Borow, and D.H. Sarne Myocardial mechanics in hyperthyroidism: Importance of left ventricular loading conditions, heart rate and contractile state J Am Coll Cardiol 7 1986 967 974 (Pubitemid 16103092)
20. G. Mintz, R. Pizzarello, and I. Klein Enhanced left ventricular diastolic function in hyperthyroidism: Noninvasive assessment and response to treatment J Clin Endocrinol Metab 73 1991 146 150 (Pubitemid 21901113)
21. W.H. Dillmann Cellular action of thyroid hormone on the heart Thyroid 12 2002 447 452 (Pubitemid 34721539)
22. E. Kiss, G. Jakab, and E.G. Kranias Thyroid hormone-induced alterations in phospholamban protein expression Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation Circ Res 75 1994 245 251
23. H.A. Kontos, W. Shapiro, and H.P. Mauck Jr Mechanism of certain abnormalities of the circulation to the limbs in thyrotoxicosis J Clin Invest 44 1965 947 956
24. S.M. Lee, T.S. Jung, and J.R. Hahm Thyrotoxicosis with coronary spasm that required coronary artery bypass surgery Intern Med 46 2007 1915 1918
25. M. Dorr, B. Wolff, and D.M. Robinson The association of thyroid function with cardiac mass and left ventricular hypertrophy J Clin Endocrinol Metab 90 2005 673 677 (Pubitemid 40279178)
26. I. Klein, and C. Hong Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart J Clin Invest 77 1986 1694 1698 (Pubitemid 16047117)
27. B. Biondi, S. Fazio, and C. Carella Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine J Clin Endocrinol Metab 78 1994 1028 1033 (Pubitemid 24143018)
28. R.J. Tomanek, M.K. Doty, and A. Sandra Early coronary angiogenesis in response to thyroxine: Growth characteristics and upregulation of basic fibroblast growth factor Circ Res 82 1998 587 593 (Pubitemid 28129029)
29. X. Wang, W. Zheng, and L.P. Christensen DITPA stimulates bFGF, VEGF, angiopoietin, and Tie-2 and facilitates coronary arteriolar growth Am J Physiol Heart Circ Physiol 284 2003 H613 H618 (Pubitemid 36142889)
30. L. Anjos-Ramos, M.S. Carneiro-Ramos, and G.P. Diniz Early cardiac hypertrophy induced by thyroxine is accompanied by an increase in VEGF-A expression but not by an increase in capillary density Virchows Arch 448 2006 472 479
31. M.K. Luidens, S.A. Mousa, and F.B. Davis Thyroid hormone and angiogenesis Vascul Pharmacol 52 2010 142 145
32. K.C. Das, M. Mukherjee, and T.K. Sarkar Erythropoiesis and erythropoietin in hypo- and hyperthyroidism J Clin Endocrinol Metab 40 1975 211 220
33. M.L. Barreto-Chaves, M.A. Carrillo-Sepulveda, and M.S. Carneiro-Ramos The crosstalk between thyroid hormones and the renin-angiotensin system Vascul Pharmacol 52 2010 166 170
34. L.M. Resnick, and J.H. Laragh PLasma renin activity in syndromes of thyroid hormone excess and deficiency Life Sci 30 1982 585 586 (Pubitemid 12151867)
35. I. Klein, and K. Ojamaa Thyroid hormone and the cardiovascular system N Engl J Med 344 2001 501 509 (Pubitemid 32164903)
36. B. Biondi, E.A. Palmieri, and G. Lombardi Effects of thyroid hormone on cardiac function: The relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism J Clin Endocrinol Metab 87 2002 968 974 (Pubitemid 36121048)
37. G.J. Kahaly, C. Kampmann, and S. Mohr-Kahaly Cardiovascular hemodynamics and exercise tolerance in thyroid disease Thyroid 12 2002 473 481 (Pubitemid 34721543)
38. J.C. Forfar, A.L. Muir, and S.A. Sawers Abnormal left ventricular function in hyperthyroidism: Evidence for a possible reversible cardiomyopathy N Engl J Med 307 1982 1165 1170 (Pubitemid 12037975)
39. E. Umana, C.A. Solares, and M.A. Alpert Tachycardia-induced cardiomyopathy Am J Med 114 2003 51 55 (Pubitemid 36126516)
40. F.E. Cruz, E.C. Cheriex, and J.L. Smeets Reversibility of tachycardia-induced cardiomyopathy after cure of incessant supraventricular tachycardia J Am Coll Cardiol 16 1990 739 744 (Pubitemid 20296141)
41. B. Nayak, and K. Burman Thyrotoxicosis and thyroid storm Endocrinol Metab Clin North Am 35 2006 663 686 (Pubitemid 44802966)
42. M. Marvisi, M. Brianti, and G. Marani Hyperthyroidism and pulmonary hypertension Respir Med 96 2002 215 220
43. R. Wasseem, E. Mazen, and S.R. Walid Hyperthyroidism: A rare cause of reversible pulmonary hypertension Am J Med Sci 332 2006 140 141 (Pubitemid 44401236)
44. T. Inukai, K. Takanashi, and H. Kobayashi Power spectral analysis of variations in heart rate in patients with hyperthyroidism or hypothyroidism Horm Metab Res 30 1998 531 535 (Pubitemid 28420076)
45. A. Mansen, C. Tiselius, and P. Sand Thyroid hormone receptor alpha can control action potential duration in mouse ventricular myocytes through the KCNE1 ion channel subunit Acta Physiol (Oxf) 198 2010 133 142
46. C. Pantos, C. Mourouzis, and M. Katramadou Decreased vascular reactivity to alpha1 adrenergic stimulation in the presence of hypothyroid state: A part of an adaptive response? Int Angiol 25 2006 216 220 (Pubitemid 44043721)
47. R.E. Beekman, C. van Hardeveld, and W.S. Simonides On the mechanism of the reduction by thyroid hormone of beta-adrenergic relaxation rate stimulation in rat heart Biochem J 259 1989 229 236 (Pubitemid 19100519)
48. M.J. Daly, and N.S. Dhalla Alterations in the cardiac adenylate cyclase activity in hypothyroid rat Can J Cardiol 1 1985 288 293 (Pubitemid 15236915)
49. J. Lekakis, C. Papamichael, and M. Alevizaki Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values Thyroid 7 1997 411 414 (Pubitemid 27295140)
50. S. Taddei, N. Caraccio, and A. Virdis Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: Beneficial effect of levothyroxine therapy J Clin Endocrinol Metab 88 2003 3731 3737 (Pubitemid 37034521)
51. J. Dernellis, and M. Panaretou Effects of thyroid replacement therapy on arterial blood pressure in patients with hypertension and hypothyroidism Am Heart J 143 2002 718 724 (Pubitemid 34454707)
52. I. Klein, and S. Danzi Thyroid disease and the heart Circulation 116 2007 1725 1735 (Pubitemid 47537847)
53. W.F. Crowley Jr, E.C. Ridgway, and E.W. Bough Noninvasive evaluation of cardiac function in hypothyroidism Response to gradual thyroxine replacement N Engl J Med 296 1977 1 6 (Pubitemid 8011909)
54. B. Biondi Cardiovascular effects of mild hypothyroidism Thyroid 17 2007 625 630 (Pubitemid 47311550)
55. V.K. Virtanen, H.H. Saha, and K.W. Groundstroem Thyroid hormone substitution therapy rapidly enhances left-ventricular diastolic function in hypothyroid patients Cardiology 96 2001 59 64 (Pubitemid 33153172)
56. P.W. Ladenson, S.I. Sherman, and K.L. Baughman Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism Proc Natl Acad Sci U S A 89 1992 5251 5255
57. K. Ojamaa, A. Kenessey, and I. Klein Thyroid hormone regulation of phospholamban phosphorylation in the rat heart Endocrinology 141 2000 2139 2144 (Pubitemid 32274367)
58. A.N. Carr, and E.G. Kranias Thyroid hormone regulation of calcium cycling proteins Thyroid 12 2002 453 457 (Pubitemid 34721540)
59. S.F. Khoury, B.D. Hoit, and V. Dave Effects of thyroid hormone on left ventricular performance and regulation of contractile and Ca(2+)-cycling proteins in the baboon Implications for the force-frequency and relaxation-frequency relationships Circ Res 79 1996 727 735 (Pubitemid 26317820)
60. E.T. Tielens, M. Pillay, and C. Storm Cardiac function at rest in hypothyroidism evaluated by equilibrium radionuclide angiography Clin Endocrinol (Oxf) 50 1999 497 502 (Pubitemid 29193234)
61. R.M. McAllister, R.W. Ogilvie, and R.L. Terjung Functional and metabolic consequences of skeletal muscle remodeling in hypothyroidism Am J Physiol 260 1991 E272 E279
62. K.M. Baldwin, A.M. Hooker, and R.E. Herrick Respiratory capacity and glycogen depletion in thyroid-deficient muscle J Appl Physiol 49 1980 102 106 (Pubitemid 10043026)
63. A. Ripoli, A. Pingitore, and B. Favilli Does subclinical hypothyroidism affect cardiac pump performance? Evidence from a magnetic resonance imaging study J Am Coll Cardiol 45 2005 439 445 (Pubitemid 40186797)
64. U.M. Kabadi, and S.P. Kumar Pericardial effusion in primary hypothyroidism Am Heart J 120 1990 1393 1395
65. C. Oliver, F. Marin, and J. Pineda Low QRS voltage in cardiac tamponade: A study of 70 cases Int J Cardiol 83 2002 91 92 (Pubitemid 34311885)
66. I. Klein, P. Mantell, and M. Parker Resolution of abnormal muscle enzyme studies in hypothyroidism Am J Med Sci 279 1980 159 162 (Pubitemid 10039616)
67. E. Galli, A. Pingitore, and G. Iervasi The role of thyroid hormone in the pathophysiology of heart failure: clinical evidence Heart Fail Rev 15 2010 155 169
68. K. Ojamaa, A. Kenessey, and R. Shenoy Thyroid hormone metabolism and cardiac gene expression after acute myocardial infarction in the rat Am J Physiol Endocrinol Metab 279 2000 E1319 E1324
69. A.R. Cappola, and P.W. Ladenson Hypothyroidism and atherosclerosis J Clin Endocrinol Metab 88 2003 2438 2444 (Pubitemid 36724408)
70. M.M. Mya, and W.S. Aronow Subclinical hypothyroidism is associated with coronary artery disease in older persons J Gerontol A Biol Sci Med Sci 57 2002 M658 M659
71. A. Orzechowska-Pawilojc, K. Sworczak, and A. Lewczuk Homocysteine, folate and cobalamin levels in hypothyroid women before and after treatment Endocr J 54 2007 471 476 (Pubitemid 47105437)
72. R. Chadarevian, E. Bruckert, and L. Leenhardt Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism J Clin Endocrinol Metab 86 2001 732 737 (Pubitemid 32207488)
73. J.J. Abrams, and S.M. Grundy Cholesterol metabolism in hypothyroidism and hyperthyroidism in man J Lipid Res 22 1981 323 338 (Pubitemid 11125136)
74. R.P. Karlsberg, D.A. Friscia, and W.S. Aronow Deleterious influence of hypothyroidism on evolving myocardial infarction in conscious dogs J Clin Invest 67 1981 1024 1034 (Pubitemid 11090540)
75. R.W. Flynn, S.R. Bonellie, and R. Jung Serum thyroid-stimulating hormone concentration and morbidity from cardiovascular disease and fractures in patients on long-term thyroxine therapy J Clin Endocrinol Metab 95 2001 186 193
76. K. Oe, T. Yamagata, and K. Mori Acute myocardial infarction following hormone replacement in hypothyroidism Int Heart J 48 2007 107 111 (Pubitemid 46522738)
77. T. Taguchi, Y. Iwasaki, and K. Asaba Myxedema coma and cardiac ischemia in relation to thyroid hormone replacement therapy in a 38-year-old Japanese woman Clin Ther 29 2007 2710 2714
78. P.D. Myerowitz, R.W. Kamienski, and D.K. Swanson Diagnosis and management of the hypothyroid patient with chest pain J Thorac Cardiovasc Surg 86 1983 57 60 (Pubitemid 13071681)
79. A.D. Toft Thyroxine therapy N Engl J Med 331 1994 174 180 (Pubitemid 24209569)
80. L. Alexander, D. Appleton, and R. Hall Epidemiology of acromegaly in the Newcastle region Clin Endocrinol (Oxf) 12 1980 71 79 (Pubitemid 10174985)
81. B.A. Bengtsson, S. Eden, and I. Ernest Epidemiology and long-term survival in acromegaly A study of 166 cases diagnosed between 1955 and 1984 Acta Med Scand 223 1988 327 335
82. B.C. Cunningham, M. Ultsch, and A.M. De Vos Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule Science 254 1991 821 825 (Pubitemid 21917402)
83. G. Baumann, J.G. MacCart, and K. Amburn The molecular nature of circulating growth hormone in normal and acromegalic man: Evidence for a principal and minor monomeric forms J Clin Endocrinol Metab 56 1983 946 952 (Pubitemid 13135173)
84. R.V. Lloyd, M. Cano, and W.F. Chandler Human growth hormone and prolactin secreting pituitary adenomas analyzed by in situ hybridization Am J Pathol 134 1989 605 613 (Pubitemid 19082854)
85. L.A. Frohman, and J.O. Jansson Growth hormone-releasing hormone Endocr Rev 7 1986 223 253
86. S. Melmed, C. Ezrin, and K. Kovacs Acromegaly due to secretion of growth hormone by an ectopic pancreatic islet-cell tumor N Engl J Med 312 1985 9 17 (Pubitemid 15181456)
87. T. Sano, S.L. Asa, and K. Kovacs Growth hormone-releasing hormone-producing tumors: Clinical, biochemical, and morphological manifestations Endocr Rev 9 1988 357 373
88. D. Le Roith, L. Scavo, and A. Butler What is the role of circulating IGF-I? Trends Endocrinol Metab 12 2001 48 52
89. G.S. Tannenbaum, J. Epelbaum, and C.Y. Bowers Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion Endocrinology 144 2003 967 974 (Pubitemid 36262864)
90. G.S. Tannenbaum, and N. Ling The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion Endocrinology 115 1984 1952 1957 (Pubitemid 15206619)
91. I.M. Holdaway, R.C. Rajasoorya, and G.D. Gamble Factors influencing mortality in acromegaly J Clin Endocrinol Metab 89 2004 667 674 (Pubitemid 38269875)
92. D. Jenkins, I. O'Brien, and A. Johnson The Birmingham pituitary database: Auditing the outcome of the treatment of acromegaly Clin Endocrinol (Oxf) 43 1995 517 522
93. R. Lopez-Velasco, H.F. Escobar-Morreale, and B. Vega Cardiac involvement in acromegaly: Specific myocardiopathy or consequence of systemic hypertension? J Clin Endocrinol Metab 82 1997 1047 1053 (Pubitemid 27166640)
94. G. Deray, M. Rieu, and M.A. Devynck Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly N Engl J Med 316 1987 575 580 (Pubitemid 17024479)
95. I. Kartal, H. Oflaz, and B. Pamukcu Investigation of early atherosclerotic changes in acromegalic patients Int J Clin Pract 64 2010 39 44
96. H. Sakai, K. Tsuchiya, and C. Nakayama Improvement of endothelial dysfunction in acromegaly after transsphenoidal surgery Endocr J 55 2008 853 859
97. B.L. Herrmann, M. Severing, and A. Schmermund Impact of disease duration on coronary calcification in patients with acromegaly Exp Clin Endocrinol Diabetes 117 2009 417 422
98. H. Akutsu, J. Kreutzer, and G. Wasmeier Acromegaly per se does not increase the risk for coronary artery disease Eur J Endocrinol 162 2010 879 886
99. P. Maffei, C. Menegazzo, and M. Michelotto Sudden death due to aortic rupture in acromegaly Heart Vessels 23 2008 71 74 (Pubitemid 351266892)
100. A.A. van der Klaauw, J.J. Bax, and J.W. Smit Increased aortic root diameters in patients with acromegaly Eur J Endocrinol 159 2008 97 103
101. B.J. Thompson, C.A. Shang, and M.J. Waters Identification of genes induced by growth hormone in rat liver using cDNA arrays Endocrinology 141 2000 4321 4324
102. C. Erikstrup, L.M. Pedersen, and L. Heickendorff Production of hyaluronan and chondroitin sulphate proteoglycans from human arterial smooth muscleThe effect of glucose, insulin, IGF-I or growth hormone Eur J Endocrinol 145 2001 193 198 (Pubitemid 32707606)
103. A. Bruel, and H. Oxlund Biosynthetic growth hormone increases the collagen deposition rate in rat aorta and heart Eur J Endocrinol 132 1995 195 199
104. S.M. Ondreyco, H.D. Lewis Jr, and C.R. Hartman Myxomatous degeneration and cystic medial necrosis associated with acromegaly Arch Intern Med 140 1980 547 549 (Pubitemid 10156663)
105. A. Colao, L. Spinelli, and P. Marzullo High prevalence of cardiac valve disease in acromegaly: An observational, analytical, case-control study J Clin Endocrinol Metab 88 2003 3196 3201 (Pubitemid 36877494)
106. J.T. Lie Pathology of the heart in acromegaly: Anatomic findings in 27 autopsied patients Am Heart J 100 1980 41 52 (Pubitemid 10083045)
107. A.M. Pereira, S.W. van Thiel, and J.R. Lindner Increased prevalence of regurgitant valvular heart disease in acromegaly J Clin Endocrinol Metab 89 2004 71 75 (Pubitemid 38183861)
108. F. Bogazzi, M. Lombardi, and E. Strata High prevalence of cardiac hypertophy without detectable signs of fibrosis in patients with untreated active acromegaly: An in vivo study using magnetic resonance imaging Clin Endocrinol (Oxf) 68 2008 361 368 (Pubitemid 351257853)
109. S. Fazio, A. Cittadini, and D. Sabatini Evidence for biventricular involvement in acromegaly: A Doppler echocardiographic study Eur Heart J 14 1993 26 33 (Pubitemid 23092635)
110. M. Galderisi, G. Vitale, and A. Bianco Pulsed tissue Doppler identifies subclinical myocardial biventricular dysfunction in active acromegaly Clin Endocrinol (Oxf) 64 2006 390 397
111. J. Hradec, J. Marek, and J. Petrasek The nature of cardiac hypertrophy in acromegaly: An echocardiographic study Cor Vasa 30 1988 186 199
112. J. Aono, S. Nobuoka, and J. Nagashima Heart failure in 3 patients with acromegaly: Echocardiographic assessment Intern Med 37 1998 599 603 (Pubitemid 128519098)
113. A. Colao Are patients with acromegaly at high risk for dysrhythmias? Clin Endocrinol (Oxf) 55 2001 305 306 (Pubitemid 32823039)
114. G. Kahaly, K.V. Olshausen, and S. Mohr-Kahaly Arrhythmia profile in acromegaly Eur Heart J 13 1992 51 56
115. B.L. Herrmann, C. Bruch, and B. Saller Occurrence of ventricular late potentials in patients with active acromegaly Clin Endocrinol (Oxf) 55 2001 201 207 (Pubitemid 32868584)
116. C. Rajasoorya, I.M. Holdaway, and P. Wrightson Determinants of clinical outcome and survival in acromegaly Clin Endocrinol (Oxf) 41 1994 95 102 (Pubitemid 24232533)
117. P. Marzullo, A. Cuocolo, and D. Ferone Cardiac effect of thyrotoxicosis in acromegaly J Clin Endocrinol Metab 85 2000 1426 1432 (Pubitemid 32289482)
118. R.R. Grunstein, K.K. Ho, and C.E. Sullivan Effect of octreotide, a somatostatin analog, on sleep apnea in patients with acromegaly Ann Intern Med 121 1994 478 483
119. L.M. Fatti, M. Scacchi, and E. Lavezzi Effects of treatment with somatostatin analogues on QT interval duration in acromegalic patients Clin Endocrinol (Oxf) 65 2006 626 630 (Pubitemid 44583823)
120. F. Bogazzi, G. Rossi, and M. Lombardi Effect of rosiglitazone on serum Igf1 concentrations in uncontrolled acromegalic patients under conventional medical therapy: Results from a pilot phase 2 study J Endocrinol Invest 2010 [Epub ahead of print]
121. M.A. Maggard, J.B. O'Connell, and C.Y. Ko Updated population-based review of carcinoid tumors Ann Surg 240 2004 117 122 (Pubitemid 38808243)
122. E.T. Janson, L. Holmberg, and M. Stridsberg Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center Ann Oncol 8 1997 685 690 (Pubitemid 27372168)
123. D.H. Harpole Jr, J.M. Feldman, and S. Buchanan Bronchial carcinoid tumors: A retrospective analysis of 126 patients Ann Thorac Surg 54 1992 50 54
124. V.G. Wong, and K.L. Melmon Ophthalmic manifestations of the carcinoid flush N Engl J Med 277 1967 406 409
125. I. Norheim, K. Oberg, and E. Theodorsson-Norheim Malignant carcinoid tumors An analysis of 103 patients with regard to tumor localization, hormone production, and survival Ann Surg 206 1987 115 125 (Pubitemid 17104952)
126. J.I. Robertson, W.S. Peart, and T.M. Andrews The mechanism of facial flushes in the carcinoid syndrome Q J Med 31 1962 103 123
127. R.F. Furchgott, and J.V. Zawadzki The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine Nature 288 1980 373 376 (Pubitemid 11169009)
128. W. Creutzfeldt, and F. Stockmann Carcinoids and carcinoid syndrome Am J Med 82 1987 4 16
129. C. Matuchansky, and J.M. Launay Serotonin, catecholamines, and spontaneous midgut carcinoid flush: Plasma studies from flushing and nonflushing sites Gastroenterology 108 1995 743 751
130. I. Norheim, E. Theodorsson-Norheim, and E. Brodin Tachykinins in carcinoid tumors: Their use as a tumor marker and possible role in the carcinoid flush J Clin Endocrinol Metab 63 1986 605 612 (Pubitemid 16050558)
131. E. Theodorsson-Norheim, I. Norheim, and K. Oberg Neuropeptide K: A major tachykinin in plasma and tumor tissues from carcinoid patients Biochem Biophys Res Commun 131 1985 77 83 (Pubitemid 16251120)
132. J.M. Conlon, C.F. Deacon, and G. Richter Measurement and partial characterization of the multiple forms of neurokinin A-like immunoreactivity in carcinoid tumours Regul Pept 13 1986 183 196 (Pubitemid 16179144)
133. J. Gustafsen, S. Boesby, and F. Nielsen Bradykinin in carcinoid syndrome Gut 28 1987 1417 1419 (Pubitemid 17164073)
134. K.J. Lucas, and J.M. Feldman Flushing in the carcinoid syndrome and plasma kallikrein Cancer 58 1986 2290 2293 (Pubitemid 17170911)
135. C.J. Gilligan, G.P. Lawton, and L.H. Tang Gastric carcinoid tumors: The biology and therapy of an enigmatic and controversial lesion Am J Gastroenterol 90 1995 338 352
136. L.J. Roberts 2nd, Z.T. Bloomgarden, and S.R. Marney Jr Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin Gastroenterology 84 1983 272 275 (Pubitemid 13224265)
137. P.A. Pellikka, A.J. Tajik, and B.K. Khandheria Carcinoid heart disease Clinical and echocardiographic spectrum in 74 patients Circulation 87 1993 1188 1196 (Pubitemid 23110391)
138. J. Waltenberger, L. Lundin, and K. Oberg Involvement of transforming growth factor-beta in the formation of fibrotic lesions in carcinoid heart disease Am J Pathol 142 1993 71 78 (Pubitemid 23026911)
139. R.D. Beauchamp, R.J. Coffey Jr, and R.M. Lyons Human carcinoid cell production of paracrine growth factors that can stimulate fibroblast and endothelial cell growth Cancer Res 51 1991 5253 5260
140. A. Chaudhry, V. Papanicolaou, and K. Oberg Expression of platelet-derived growth factor and its receptors in neuroendocrine tumors of the digestive system Cancer Res 52 1992 1006 1012
141. H.M. Connolly, J.L. Crary, and M.D. McGoon Valvular heart disease associated with fenfluramine-phentermine N Engl J Med 337 1997 581 588 (Pubitemid 27360757)
142. B.I. Gustafsson, K. Tommeras, and I. Nordrum Long-term serotonin administration induces heart valve disease in rats Circulation 111 2005 1517 1522 (Pubitemid 40470647)
143. L. Terracio, L. Ronnstrand, and A. Tingstrom Induction of platelet-derived growth-factor receptor expression in smooth-muscle cells and fibroblasts upon tissue culturing J Cell Biol 107 1988 1947 1957 (Pubitemid 18263555)
144. S. Bhattacharyya, C. Toumpanakis, and M. Burke Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI Circ Cardiovasc Imaging 3 2010 103 111
145. L. Lundin, I. Norheim, and J. Landelius Carcinoid heart disease: Relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities Circulation 77 1988 264 269 (Pubitemid 18060033)
146. M.B. Jacobsen, S. Nitterhauge, and P.E. Bryde Cardiac manifestations in midgut carcinoid disease Eur Heart J 16 1995 263 268
147. J.G. Castillo, F. Filsoufi, and D.H. Adams Management of patients undergoing multivalvular surgery for carcinoid heart disease: The role of the anaesthetist Br J Anaesth 101 2008 618 626
148. A.H. Limper, P.C. Carpenter, and B. Scheithauer The Cushing syndrome induced by bronchial carcinoid-tumors Ann Intern Med 117 1992 209 214
149. D.G. Carroll, J.W. Delahunt, and C.A. Teague Resolution of acromegaly after removal of a bronchial carcinoid shown to secrete growth-hormone releasing-factor Aust N Z J Med 17 1987 63 67 (Pubitemid 17109124)
150. H.H. Whitman 3rd, E.K. Fishman, and K. Oberg Catecholamine-secreting metastatic carcinoid as differential diagnosis in pheochromocytoma: Clinical, laboratory, and imaging clues in the search for the lurking neuroendocrine tumor (NET) Ann N Y Acad Sci 1073 2006 59 78 (Pubitemid 44911999)
151. J.M. Feldman Carcinoid tumors and syndrome Semin Oncol 14 1987 237 246
152. J. Etxabe, and J.A. Vazquez Morbidity and mortality in Cushing's disease: An epidemiological approach Clin Endocrinol (Oxf) 40 1994 479 484 (Pubitemid 24194645)
153. L. Wei, T.M. MacDonald, and B.R. Walker Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease Ann Intern Med 141 2004 764 770
154. J.D. Baxter, J.W. Funder, and J.W. Apriletti Towards selectively modulating mineralocorticoid receptor function: Lessons from other systems Mol Cell Endocrinol 217 2004 151 165 (Pubitemid 38596640)
155. M. Pirpiris, S. Yeung, and E. Dewar Hydrocortisone-induced hypertension in men The role of cardiac output Am J Hypertens 6 1993 287 294 (Pubitemid 23140986)
156. J.A. Whitworth, D. Gordon, and J. Andrews The hypertensive effect of synthetic glucocorticoids in man: Role of sodium and volume J Hypertens 7 1989 537 549 (Pubitemid 19189576)
157. P.M. Williamson, J.J. Kelly, and J.A. Whitworth Dose-response relationships and mineralocorticoid activity in cortisol-induced hypertension in humans J Hypertens Suppl 14 1996 S37 S41 (Pubitemid 27051076)
158. D.A. Scheuer, and A.G. Bechtold Glucocorticoids potentiate central actions of angiotensin to increase arterial pressure Am J Physiol Regul Integr Comp Physiol 280 2001 R1719 R1726
159. S.H. Tam, J.J. Kelly, and P.M. Williamson Reflex sympathetic function in cortisol-induced hypertension in humans Clin Exp Hypertens 19 1997 479 493 (Pubitemid 27246094)
160. S.H. Tam, P.M. Williamson, and J.J. Kelly Autonomic blockade amplifies cortisol-induced hypertension in man Clin Exp Pharmacol Physiol 24 1997 31 33 (Pubitemid 27101487)
161. F. Fallo, P. Maffei, and A. Dalla Pozza Cardiovascular autonomic function in Cushing's syndrome J Endocrinol Invest 32 2009 41 45
162. M. Sakaue, and B.B. Hoffman Glucocorticoids induce transcription and expression of the alpha 1B adrenergic receptor gene in DTT1 MF-2 smooth muscle cells J Clin Invest 88 1991 385 389
163. A. Sato, H. Suzuki, and M. Murakami Glucocorticoid increases angiotensin II type 1 receptor and its gene expression Hypertension 23 1994 25 30 (Pubitemid 24022040)
164. C. Klett, D. Ganten, and W. Hellmann Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones Endocrinology 130 1992 3660 3668
165. G. Kirilov, A. Tomova, and L. Dakovska Elevated plasma endothelin as an additional cardiovascular risk factor in patients with Cushing's syndrome Eur J Endocrinol 149 2003 549 553 (Pubitemid 38054699)
166. S. Heidenreich, K.H. Rahn, and W. Zidek Direct vasopressor effect of recombinant human erythropoietin on renal resistance vessels Kidney Int 39 1991 259 265
167. J.J. Kelly, A. Martin, and J.A. Whitworth Role of erythropoietin in cortisol-induced hypertension J Hum Hypertens 14 2000 195 198 (Pubitemid 30153633)
168. L. Smith, and J.B. Smith Regulation of sodium-calcium exchanger by glucocorticoids and growth factors in vascular smooth muscle J Biol Chem 269 1994 27527 27531 (Pubitemid 24346582)
169. C.M. Ritchie, B. Sheridan, and R. Fraser Studies on the pathogenesis of hypertension in Cushing's disease and acromegaly Q J Med 76 1990 855 867 (Pubitemid 20244075)
170. G.J. Mangos, B.R. Walker, and J.J. Kelly Cortisol inhibits cholinergic vasodilation in the human forearm Am J Hypertens 13 2000 1155 1160
171. W.W. Simmons, D. Ungureanu-Longrois, and G.K. Smith Glucocorticoids regulate inducible nitric oxide synthase by inhibiting tetrahydrobiopterin synthesis and L-arginine transport J Biol Chem 271 1996 23928 23937 (Pubitemid 26327368)
172. K. Yasunari, M. Kohno, and K. Murakawa Glucocorticoids and atrial natriuretic factor receptors on vascular smooth muscle Hypertension 16 1990 581 586 (Pubitemid 20368348)
173. E. Porteri, D. Rizzoni, and M.J. Mulvany Adrenergic mechanisms and remodeling of subcutaneous small resistance arteries in humans J Hypertens 21 2003 2345 2352 (Pubitemid 38293575)
174. D. Rizzoni, Enzo Porteri, and C. De Ciuceis Hypertrophic remodeling of subcutaneous small resistance arteries in patients with Cushing's syndrome J Clin Endocrinol Metab 94 2009 5010 5018
175. A.M. Heagerty, C. Aalkjaer, and S.J. Bund Small artery structure in hypertension Dual processes of remodeling and growth Hypertension 21 1993 391 397 (Pubitemid 23095149)
176. A.M. Pereira, V. Delgado, and J.A. Romijn Cardiac dysfunction is reversed
177. J.E. Shipley, D.E. Schteingart, and R. Tandon Sleep architecture and sleep apnea in patients with Cushing's disease Sleep 15 1992 514 518
178. A. Faggiano, R. Pivonello, and S. Spiezia Cardiovascular risk factors and common carotid artery caliber and stiffness in patients with Cushing's disease during active disease and 1 year after disease remission J Clin Endocrinol Metab 88 2003 2527 2533 (Pubitemid 36724418)
179. G. Benker, M. Raida, and T. Olbricht TSH secretion in Cushing's syndrome: Relation to glucocorticoid excess, diabetes, goitre, and the 'sick euthyroid syndrome.' Clin Endocrinol (Oxf) 33 1990 777 786
180. K. Chakravarty, H. Cassuto, and L. Reshef Factors that control the tissue-specific transcription of the gene for phosphoenolpyruvate carboxykinase-C Crit Rev Biochem Mol Biol 40 2005 129 154 (Pubitemid 40834294)
181. L.M. Watts, V.P. Manchem, and T.A. Leedom Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism Diabetes 54 2005 1846 1853 (Pubitemid 40770776)
182. J.M. Olefsky Effect of dexamethasone on insulin binding, glucose transport, and glucose oxidation of isolated rat adipocytes J Clin Invest 56 1975 1499 1508
183. M. Boscaro, N. Sonino, and A. Scarda Anticoagulant prophylaxis markedly reduces thromboembolic complications in Cushing's syndrome J Clin Endocrinol Metab 87 2002 3662 3666 (Pubitemid 34879509)
184. A. La Brocca, M. Terzolo, and A. Pia Recurrent thromboembolism as a hallmark of Cushing's syndrome J Endocrinol Invest 20 1997 211 214 (Pubitemid 27289381)
185. L.M. Fatti, B. Bottasso, and C. Invitti Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome J Endocrinol Invest 23 2000 145 150 (Pubitemid 30218782)
186. M. Terzolo, B. Allasino, and S. Bosio Hyperhomocysteinemia in patients with Cushing's syndrome J Clin Endocrinol Metab 89 2004 3745 3751 (Pubitemid 39071467)
187. J.A. Carney, H. Gordon, and P.C. Carpenter The complex of myxomas, spotty pigmentation, and endocrine overactivity Medicine (Baltimore) 64 1985 270 283 (Pubitemid 16247109)
188. P.M. McCarthy, J.M. Piehler, and H.V. Schaff The significance of multiple, recurrent, and "complex" cardiac myxomas J Thorac Cardiovasc Surg 91 1986 389 396 (Pubitemid 16118000)
189. C.A. Stratakis, L.S. Kirschner, and J.A. Carney Clinical and molecular features of the Carney complex: Diagnostic criteria and recommendations for patient evaluation J Clin Endocrinol Metab 86 2001 4041 4046 (Pubitemid 32848510)
190. W. Arlt, and B. Allolio Adrenal insufficiency Lancet 361 2003 1881 1893 (Pubitemid 36645187)
191. W. Oelkers Adrenal insufficiency N Engl J Med 335 1996 1206 1212
192. R.M. Carey The changing clinical spectrum of adrenal insufficiency Ann Intern Med 127 1997 1103 1105 (Pubitemid 28012081)
193. G. Piedrola, J.L. Casado, and E. Lopez Clinical features of adrenal insufficiency in patients with acquired immunodeficiency syndrome Clin Endocrinol (Oxf) 45 1996 97 101 (Pubitemid 26248938)
194. S. Nishizawa, T. Nakamura, and T. Hamaoka Lethal arrhythmia and corticosteroid insufficiency Am J Emerg Med 27 2009 1167 e1-e3
195. B.A. Boston, C. DeGroff, and C.E. Hanna Reversible cardiomyopathy in an infant with unrecognized congenital adrenal hyperplasia J Pediatr 124 1994 936 938 (Pubitemid 24184022)
196. A. Afzal, and F. Khaja Reversible cardiomyopathy associated with Addison's disease Can J Cardiol 16 2000 377 379 (Pubitemid 30197751)
197. M. Derish, K. Eckert, and C. Chin Reversible cardiomyopathy in a child with Addison's disease Intensive Care Med 22 1996 460 463 (Pubitemid 26174322)
198. N. Narayanan Effects of adrenalectomy and in vivo administration of dexamethasone on ATP-dependent calcium accumulation by sarcoplasmic reticulum from rat heart J Mol Cell Cardiol 15 1983 7 15 (Pubitemid 13144476)
199. N. Narayanan, and R.L. Khandelwal Microsomal phosphorylase in rat heart: Depletion following adrenalectomy and restoration by in vivo administration of dexamethasone Endocrinology 117 1989 1544 1549 (Pubitemid 15238136)
200. T.B. Miller, J.H. Exton, and C.R. Park A block in epinephrine-induced glycogenolysis in hearts from adrenalectomized rats J Biol Chem 246 1971 3672 3678
201. Z. Chen, A.W. Murray, and J.J. Quinlan Pituitary apoplexy presenting as unilateral third cranial nerve palsy after coronary artery bypass surgery Anesth Analg 98 2004 46 48 (Pubitemid 38029839)
202. E. Levy, A. Korach, and G. Merin Pituitary apoplexy and CABG: Should we change our strategy? Ann Thorac Surg 84 2007 1388 1390 (Pubitemid 47417883)
203. T.H. Jurney, J.L. Cockrell Jr, and J.S. Lindberg Spectrum of serum cortisol response to ACTH in ICU patients Correlation with degree of illness and mortality Chest 92 1987 292 295 (Pubitemid 17125833)
204. P.E. Marik, and G.P. Zaloga Adrenal insufficiency in the critically ill: A new look at an old problem Chest 122 2002 1784 1796 (Pubitemid 35366095)
205. R.I. Dorin, C.R. Qualls, and L.M. Crapo Diagnosis of adrenal insufficiency Ann Intern Med 139 2003 194 204 (Pubitemid 38124602)
206. J.L. Iribarren, J.J. Jimenez, and D. Hernandez Relative adrenal insufficiency and hemodynamic status in cardiopulmonary bypass surgery patients A prospective cohort study J Cardiothorac Surg 5 2010 26
207. G. Bouachour, P. Tirot, and J.P. Gouello Adrenocortical function during septic shock Intensive Care Med 21 1995 57 62
208. J.B. Lundy, M.L. Slane, and J.D. Frizzi Acute adrenal insufficiency after a single dose of etomidate J Intensive Care Med 22 2007 111 117 (Pubitemid 46548132)
209. J.F. Cotten, S.S. Husain, and S.A. Forman Methoxycarbonyl-etomidate: A novel rapidly metabolized and ultra-short-acting etomidate analogue that does not produce prolonged adrenocortical suppression Anesthesiology 111 2009 240 249
210. B.A. Cotton, O.D. Guillamondegui, and S.B. Fleming Increased risk of adrenal insufficiency following etomidate exposure in critically injured patients Arch Surg 143 2008 62 67 (Pubitemid 351159292)
211. N.V. Esteban, T. Loughlin, and A.L. Yergey Daily cortisol production rate in man determined by stable isotope dilution/mass spectrometry J Clin Endocrinol Metab 72 1991 39 45 (Pubitemid 21921653)
212. M. Salem, R.E. Tainsh Jr, and J. Bromberg Perioperative glucocorticoid coverage A reassessment 42 years after emergence of a problem Ann Surg 219 1994 416 425 (Pubitemid 24121456)
213. S.W. Lamberts, H.A. Bruining, and F.H. de Jong Corticosteroid therapy in severe illness N Engl J Med 337 1997 1285 1292 (Pubitemid 27461285)
214. R. Udelsman, J. Ramp, and W.T. Gallucci Adaptation during surgical stress A reevaluation of the role of glucocorticoids J Clin Invest 77 1986 1377 1381 (Pubitemid 16047162)
215. D.B. Coursin, and K.E. Wood Corticosteroid supplementation for adrenal insufficiency JAMA 287 2002 236 240 (Pubitemid 34251950)
216. Y.C. Chen, Y.C. Su, and J.E. Tzeng A woman with persistent chest pain and palpitations after coronary stenting Kidney Int 75 2009 1361 1362
217. Z. Cheng, S. Zhang, and Q. Fang Cardiac pheochromocytoma Eur Heart J 31 2010 2147
218. Q. Li, Q. Fan, and D. Li Nonfunctioning benign cardiac pheochromocytoma J Cancer Res Clin Oncol 135 2009 103 105
219. J. Zhou, H.T. Chen, and J. Xiang Surgical treatment of cardiac pheochromocytoma: A case report Ann Thorac Surg 88 2009 278 281
220. E.E. Elder, G. Elder, and C. Larsson Pheochromocytoma and functional paraganglioma syndrome: No longer the 10% tumor J Surg Oncol 89 2005 193 201 (Pubitemid 40315916)
221. H.P. Neumann, B. Bausch, and S.R. McWhinney Germ-line mutations in nonsyndromic pheochromocytoma N Engl J Med 346 2002 1459 1466 (Pubitemid 34755714)
222. M.L. Brandi, R.F. Gagel, and A. Angeli Guidelines for diagnosis and therapy of MEN type 1 and type 2 J Clin Endocrinol Metab 86 2001 5658 5671 (Pubitemid 33152604)
223. H.F. Vasen, M. van der Feltz, and F. Raue The natural course of multiple endocrine neoplasia type IIb A study of 18 cases Arch Intern Med 152 1992 1250 1252
224. B.U. Bender, M. Gutsche, and S. Glasker Differential genetic alterations in von Hippel-Lindau syndrome-associated and sporadic pheochromocytomas J Clin Endocrinol Metab 85 2000 4568 4574 (Pubitemid 32157635)
225. M.M. Walther, J. Herring, and E. Enquist von Recklinghausen's disease and pheochromocytomas J Urol 162 1999 1582 1586 (Pubitemid 29474665)
226. G.N. Zografos, G.K. Vasiliadis, and F. Zagouri Pheochromocytoma associated with neurofibromatosis type 1: Concepts and current trends World J Surg Oncol 8 2010 14
227. A.R. McNeil, B.H. Blok, and T.D. Koelmeyer Phaeochromocytomas discovered during coronial autopsies in Sydney, Melbourne and Auckland Aust N Z J Med 30 2000 648 652 (Pubitemid 32055962)
228. G.H. Anderson Jr, N. Blakeman, and D.H. Streeten The effect of age on prevalence of secondary forms of hypertension in 4429 consecutively referred patients J Hypertens 12 1994 609 615 (Pubitemid 24192887)
229. M. Omura, J. Saito, and K. Yamaguchi Prospective study on the prevalence of secondary hypertension among hypertensive patients visiting a general outpatient clinic in Japan Hypertens Res 27 2004 193 202 (Pubitemid 38489081)
230. A.M. Sinclair, C.G. Isles, and I. Brown Secondary hypertension in a blood pressure clinic Arch Intern Med 147 1987 1289 1293
231. J.J. Kaufman, and S. Franklin Familial pheochromocytoma: A report of 2 cases in a kindred J Urol 121 1979 801 804 (Pubitemid 9205791)
232. C.K. Kramer, C.B. Leitao, and M.J. Azevedo Degree of catecholamine hypersecretion is the most important determinant of intra-operative hemodynamic outcomes in pheochromocytoma J Endocrinol Invest 32 2009 234 237
233. E.L. Bravo Pheochromocytoma: An approach to antihypertensive management Ann N Y Acad Sci 970 2002 1 10 (Pubitemid 35286079)
234. E.L. Bravo, R.C. Tarazi, and R.W. Gifford Circulating and urinary catecholamines in pheochromocytoma Diagnostic and pathophysiologic implications N Engl J Med 301 1979 682 686 (Pubitemid 10240444)
235. M.D. Johnson, P.G. Smith, and E. Mills Paradoxical elevation of sympathetic activity during catecholamine infusion in rats J Pharmacol Exp Ther 227 1983 254 259 (Pubitemid 14205297)
236. T. Zelinka, B. Strauch, and O. Petrak Increased blood pressure variability in pheochromocytoma compared to essential hypertension patients J Hypertens 23 2005 2033 2039 (Pubitemid 41830399)
237. M. Munakata, A. Aihara, and Y. Imai Altered sympathetic and vagal modulations of the cardiovascular system in patients with pheochromocytoma: their relations to orthostatic hypotension Am J Hypertens 12 1999 572 580 (Pubitemid 29268388)
238. D.H. Streeten, and G.H. Anderson Jr Mechanisms of orthostatic hypotension and tachycardia in patients with pheochromocytoma Am J Hypertens 9 1996 760 769
239. G. Eisenhofer, T.T. Huynh, and A. Elkahloun Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma Am J Physiol Endocrinol Metab 295 2008 E1223 E1233
240. Y. Ito, Y. Fujimoto, and T. Obara The role of epinephrine, norepinephrine, and dopamine in blood pressure disturbances in patients with pheochromocytoma World J Surg 16 1992 759 763
241. L.A. Dubois, and D.K. Gray Dopamine-secreting pheochromocytomas: In search of a syndrome World J Surg 29 2005 909 913 (Pubitemid 41800727)
242. G. Eisenhofer, D.S. Goldstein, and P. Sullivan Biochemical and clinical manifestations of dopamine-producing paragangliomas: Utility of plasma methoxytyramine J Clin Endocrinol Metab 90 2005 2068 2075 (Pubitemid 40586241)
243. C. Proye, P. Fossati, and P. Fontaine Dopamine-secreting pheochromocytoma: An unrecognized entity? Classification of pheochromocytomas according to their type of secretion Surgery 100 1986 1154 1162 (Pubitemid 17223236)
244. P.D. Marley Mechanisms in histamine-mediated secretion from adrenal chromaffin cells Pharmacol Ther 98 2003 1 34 (Pubitemid 36349760)
245. E. Grazzini, C. Breton, and S. Derick Vasopressin receptors in human adrenal medulla and pheochromocytoma J Clin Endocrinol Metab 84 1999 2195 2203 (Pubitemid 30647054)
246. G.W. Sizemore, K.E. Scrogin, and E.S. Weisenberg Hypertensive crisis, catecholamine cardiomyopathy, and death associated with pseudoephedrine use in a patient with pheochromocytoma Endocr Pract 14 2008 93 96
247. A.L. Rosas, A.A. Kasperlik-Zaluska, and L. Papierska Pheochromocytoma crisis induced by glucocorticoids: A report of four cases and review of the literature Eur J Endocrinol 158 2008 423 429 (Pubitemid 351405009)
248. S.K. Baid, E.W. Lai, and R.A. Wesley Brief communication: Radiographic contrast infusion and catecholamine release in patients with pheochromocytoma Ann Intern Med 150 2009 27 32
249. R.J. Wurtman Control of epinephrine synthesis in the adrenal medulla by the adrenal cortex: Hormonal specificity and dose-response characteristics Endocrinology 79 1966 608 614
250. S. Yang, and L. Zhang Glucocorticoids and vascular reactivity Curr Vasc Pharmacol 2 2004 1 12 (Pubitemid 38855010)
251. M.R. Achong, and P.M. Keane Pheochromocytoma unmasked by desipramine therapy Ann Intern Med 94 1981 358 359 (Pubitemid 11137082)
252. A. Korzets, S. Floro, and Y. Ori Clomipramine-induced pheochromocytoma crisis: A near fatal complication of a tricyclic antidepressant J Clin Psychopharmacol 17 1997 428 430 (Pubitemid 27414404)
253. D.J. Myklejord Undiagnosed pheochromocytoma: The anesthesiologist nightmare Clin Med Res 2 2004 59 62
254. J.T. Lie, B.A. Olney, and J.A. Spittell Perioperative hypertensive crisis and hemorrhagic diathesis: Fatal complication of clinically unsuspected pheochromocytoma Am Heart J 100 1980 716 722 (Pubitemid 11226051)
255. D.A. Cross, and J.S. Meyer Postoperative deaths due to unsuspected pheochromocytoma South Med J 70 1977 1320 1321 (Pubitemid 8229455)
256. R.M. Ter Bekke, H.J. Crijns, and A.A. Kroon Pheochromocytoma-induced ventricular tachycardia and reversible cardiomyopathy Int J Cardiol 2009 [Epub ahead of print]
257. M. Park, K. Hryniewicz, and J.F. Setaro Pheochromocytoma presenting with myocardial infarction, cardiomyopathy, renal failure, pulmonary hemorrhage, and cyclic hypotension: Case report and review of unusual presentations of pheochromocytoma J Clin Hypertens (Greenwich) 11 2009 74 80
258. J.T. Ahn, J.U. Hibbard, and J.B. Chapa Atypical presentation of pheochromocytoma as part of multiple endocrine neoplasia IIa in pregnancy Obstet Gynecol 102 2003 1202 1205 (Pubitemid 37357099)
259. S.R. Jategaonkar, T. Butz, and W. Burchert Echocardiac features simulating hypertrophic obstructive cardiomyopathy in a patient with pheochromocytoma Clin Res Cardiol 98 2009 195 198
260. S.A. Wiyono, W.B. Vletter, and O.I. Soliman Thrombus in a normal left ventricle: A cardiac manifestation of pheochromocytoma Echocardiography 27 2010 195 197
261. M.K. Gervais, A. Gagnon, and M. Henri Pheochromocytoma presenting as inverted Takotsubo cardiomyopathy: A case report and review of the literature J Cardiovasc Med (Hagerstown) 2010 [Epub ahead of print]
262. S. Kimura, W. Mitsuma, and M. Ito Inverted Takotsubo contractile pattern caused by pheochromocytoma with tall upright T-waves, but not typical deep T-wave inversion Int J Cardiol 139 2010 e15 e17
263. Y. Tanriver, M.J. Betz, and L. Nibbe Sepsis and cardiomyopathy as rare clinical manifestations of pheochromocytoma: Two case report studies Exp Clin Endocrinol Diabetes 118 2010 747 753
264. H.R. Mobine, A.B. Baker, and L. Wang Pheochromocytoma-induced cardiomyopathy is modulated by the synergistic effects of cell-secreted factors Circ Heart Fail 2 2009 121 128
265. V. Jeevanandam, M.C. Oz, and B. Shapiro Surgical management of cardiac pheochromocytoma Resection versus transplantation Ann Surg 221 1995 415 419
266. O. Petrak, B. Strauch, and T. Zelinka Factors influencing arterial stiffness in pheochromocytoma and effect of adrenalectomy Hypertens Res 33 2010 454 459
267. J.M. Ng Desflurane and remifentanil use during resection of a cardiac pheochromocytoma J Cardiothorac Vasc Anesth 18 2004 630 631
268. M.A. Kinney, M.E. Warner, and J.A. van Heerden Perianesthetic risks and outcomes of pheochromocytoma and paraganglioma resection Anesth Analg 91 2000 1118 1123
269. J.C. Ulchaker, D.A. Goldfarb, and E.L. Bravo Successful outcomes in pheochromocytoma surgery in the modern era J Urol 161 1999 764 767 (Pubitemid 29422362)
270. T.N. Weingarten, J.P. Cata, and J.F. O'Hara Comparison of two preoperative medical management strategies for laparoscopic resection of pheochromocytoma Urology 76 2010 508.e6 508.e11
271. S. Welle, R. Jozefowicz, and G. Forbes Effect of testosterone on metabolic rate and body composition in normal men and men with muscular dystrophy J Clin Endocrinol Metab 74 1992 332 335
272. A. Strawford, T. Barbieri, and M. Van Loan Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: A randomized controlled trial JAMA 281 1999 1282 1290 (Pubitemid 29174479)
273. I.M. Ferreira, I.T. Verreschi, and L.E. Nery The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients Chest 114 1998 19 28 (Pubitemid 28337356)
274. R.H. Demling, and L. DeSanti Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns J Trauma 43 1997 47 51 (Pubitemid 27334929)
275. H. Kuipers, J.A. Wijnen, and F. Hartgens Influence of anabolic steroids on body composition, blood pressure, lipid profile and liver functions in body builders Int J Sports Med 12 1991 413 418
276. A. Urhausen, T. Albers, and W. Kindermann Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 90 2004 496 501 (Pubitemid 38530163)
277. D. Riebe, B. Fernhall, and P.D. Thompson The blood pressure response to exercise in anabolic steroid users Med Sci Sports Exerc 24 1992 633 637
278. F. Grace, N. Sculthorpe, and J. Baker Blood pressure and rate pressure product response in males using high-dose anabolic androgenic steroids (AAS) J Sci Med Sport 6 2003 307 312 (Pubitemid 38470137)
279. T. Chung, S. Kelleher, and P.Y. Liu Effects of testosterone and nandrolone on cardiac function: A randomized, placebo-controlled study Clin Endocrinol (Oxf) 66 2007 235 245 (Pubitemid 46096144)
280. F. Hartgens, E.C. Cheriex, and H. Kuipers Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes Int J Sports Med 24 2003 344 351 (Pubitemid 36936451)
281. R.C. Salke, T.W. Rowland, and E.J. Burke Left ventricular size and function in body builders using anabolic steroids Med Sci Sports Exerc 17 1985 701 704 (Pubitemid 16209442)
282. L. Fanton, D. Belhani, and F. Vaillant Heart lesions associated with anabolic steroid abuse: Comparison of post-mortem findings in athletes and norethandrolone-induced lesions in rabbits Exp Toxicol Pathol 61 2009 317 323
283. S. Nottin, L.D. Nguyen, and M. Terbah Cardiovascular effects of androgenic anabolic steroids in male bodybuilders determined by tissue Doppler imaging Am J Cardiol 97 2006 912 915
284. R. Matyal, P. Panzica, and N.E. Tawa Severe hemodynamic instability during general anesthesia in a professional bodybuilder J Cardiothorac Vasc Anesth 23 2009 208 210
285. W. Kindermann, and A. Urhausen Left ventricular dimensions and function in strength athletes Re: Hartgens F, Cheriex EC, Kuipers H. Prospective echocardiographic assessment of androgenic-anabolic steroids effects on cardiac structure and function in strength athletes. Int J Sports Med 2003; 24: 344 - 352 Int J Sports Med 25 2004 241 244
286. A. Urhausen, and W. Kindermann Sports-specific adaptations and differentiation of the athlete's heart Sports Med 28 1999 237 244 (Pubitemid 29520666)
287. A. Stolt, T. Karila, and M. Viitasalo QT interval and QT dispersion in endurance athletes and in power athletes using large doses of anabolic steroids Am J Cardiol 84 1999 364 366 (Pubitemid 29365145)
288. N.A. Hassan, M.F. Salem, and M.A. Sayed Doping and effects of anabolic androgenic steroids on the heart: Histological, ultrastructural, and echocardiographic assessment in strength athletes Hum Exp Toxicol 28 2009 273 283
289. H. Behrendt Effect of anabolic steroids on rat heart muscle cells I. Intermediate filaments Cell Tissue Res 180 1977 303 315 (Pubitemid 8111903)
290. H. Behrendt, and H. Boffin Myocardial cell lesions caused by an anabolic hormone Cell Tissue Res 181 1977 423 426 (Pubitemid 8141681)
291. R.B. Melchert, T.J. Herron, and A.A. Welder The effect of anabolic-androgenic steroids on primary myocardial cell cultures Med Sci Sports Exerc 24 1992 206 212
292. A.A. Welder, J.W. Robertson, and R.D. Fugate Anabolic-androgenic steroid-induced toxicity in primary neonatal rat myocardial cell cultures Toxicol Appl Pharmacol 133 1995 328 342
293. L.J. Santora, J. Marin, and J. Vangrow Coronary calcification in body builders using anabolic steroids Prev Cardiol 9 2006 198 201
294. E.M. Ammar, S.A. Said, and M.S. Hassan Enhanced vasoconstriction and reduced vasorelaxation induced by testosterone and nandrolone in hypercholesterolemic rabbits Pharmacol Res 50 2004 253 259 (Pubitemid 38844478)
295. D. Applebaum-Bowden, S.M. Haffner, and W.R. Hazzard The dyslipoproteinemia of anabolic steroid therapy: Increase in hepatic triglyceride lipase precedes the decrease in high density lipoprotein2 cholesterol Metabolism 36 1987 949 952 (Pubitemid 17160512)
296. G. Baldo-Enzi, F. Giada, and G. Zuliani Lipid and apoprotein modifications in body builders during and after self-administration of anabolic steroids Metabolism 39 1990 203 208 (Pubitemid 20053281)
297. E. Kasikcioglu, H. Oflaz, and A. Arslan Aortic elastic properties in athletes using anabolic-androgenic steroids Int J Cardiol 114 2007 132 134 (Pubitemid 44791460)
298. C.F. Ebenbichler, W. Sturm, and H. Ganzer Flow-mediated, endothelium-dependent vasodilatation is impaired in male body builders taking anabolic-androgenic steroids Atherosclerosis 158 2001 483 490 (Pubitemid 32913661)
299. H.A. Lane, F. Grace, and J.C. Smith Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids Eur J Clin Invest 36 2006 483 488 (Pubitemid 43876128)
300. A.A. Ajayi, R. Mathur, and P.V. Halushka Testosterone increases human platelet thromboxane A2 receptor density and aggregation responses Circulation 91 1995 2742 2747
301. R. Pilo, D. Aharony, and A. Raz Testosterone potentiation of ionophore and ADP induced platelet aggregation: Relationship to arachidonic acid metabolism Thromb Haemost 46 1981 538 542 (Pubitemid 11049525)
302. K. Stergiopoulos, J.J. Brennan, and R. Mathews Anabolic steroids, acute myocardial infarction and polycythemia: A case report and review of the literature Vasc Health Risk Manag 4 2008 1475 1480
303. J.L. Teruel, R. Marcen, and J.F. Navarro Evolution of serum erythropoietin after androgen administration to hemodialysis patients: A prospective study Nephron 70 1995 282 286
304. G. Ferenchick, D. Schwartz, and M. Ball Androgenic-anabolic steroid abuse and platelet aggregation: A pilot study in weight lifters Am J Med Sci 303 1992 78 82
305. N.N. Kahn, A.K. Sinha, and A.M. Spungen Effects of oxandrolone, an anabolic steroid, on hemostasis Am J Hematol 81 2006 95 100 (Pubitemid 43208596)
306. J.E. Ansell, C. Tiarks, and V.K. Fairchild Coagulation abnormalities associated with the use of anabolic steroids Am Heart J 125 1993 367 371 (Pubitemid 23055267)
307. V. Fineschi, G. Baroldi, and F. Monciotti Anabolic steroid abuse and cardiac sudden death: A pathologic study Arch Pathol Lab Med 125 2001 253 255 (Pubitemid 32167479)
308. M. Fisher, M. Appleby, and D. Rittoo Myocardial infarction with extensive intracoronary thrombus induced by anabolic steroids Br J Clin Pract 50 1996 222 223 (Pubitemid 26196281)
309. K. McCarthy, A.T. Tang, and M.J. Dalrymple-Hay Ventricular thrombosis and systemic embolism in bodybuilders: Etiology and management Ann Thorac Surg 70 2000 658 660
310. A. Alhadad, S. Acosta, and L. Sarabi Pulmonary embolism associated with protein C deficiency and abuse of anabolic-androgen steroids Clin Appl Thromb Hemost 16 2010 228 231
311. E.F. Du Toit, E. Rossouw, and J. Van Rooyen Proposed mechanisms for the anabolic steroid-induced increase in myocardial susceptibility to ischaemia/reperfusion injury Cardiovasc J S Afr 16 2005 21 28 (Pubitemid 40529777)
312. M. Parssinen, U. Kujala, and E. Vartiainen Increased premature mortality of competitive powerlifters suspected to have used anabolic agents Int J Sports Med 21 2000 225 227 (Pubitemid 30260844)
313. D.R. Goldstein, T. Dobbs, and B. Krull Clenbuterol and anabolic steroids: A previously unreported cause of myocardial infarction with normal coronary arteriograms South Med J 91 1998 780 784 (Pubitemid 28374537)
314. M.S. Nieminen, M.P. Ramo, and M. Viitasalo Serious cardiovascular side effects of large doses of anabolic steroids in weight lifters Eur Heart J 17 1996 1576 1583 (Pubitemid 26345149)
315. B.D. Phillis, M.Y. Abeywardena, and M.J. Adams Nandrolone potentiates arrhythmogenic effects of cardiac ischemia in the rat Toxicol Sci 99 2007 605 611 (Pubitemid 351753074)
316. F.L. Rocha, E.C. Carmo, and F.R. Roque Anabolic steroids induce cardiac renin-angiotensin system and impair the beneficial effects of aerobic training in rats Am J Physiol Heart Circ Physiol 293 2007 H3575 H3583 (Pubitemid 350230902)